
|Podcasts|July 30, 2020
The Importance of Secondary Biocide Supplier and Elements to Consider for Selection
Author(s)Ecolab
Trending on Pharmaceutical Technology
1
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
2
AAPS PharmSci 360: CMC Strategies, Part 1
3
AAPS PharmSci 360: Microstructure Intelligence in Predictive Drug Development, Part 1
4
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
5



